Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Acquisitions (2018)

Sunshine Biopharma (SBFM) has disclosed Acquisitions for 1 consecutive years, with $9884.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Acquisitions changed N/A year-over-year to $9884.0, compared with a TTM value of $9884.0 through Sep 2019, up 300.0%, and an annual FY2022 reading of $14.3 million, changed N/A over the prior year.
  • Acquisitions was $9884.0 for Q4 2018 at Sunshine Biopharma, up from -$85231.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $80289.0 in Q1 2018 and bottomed at -$85231.0 in Q3 2018.